newsfilter
← Latest News
PR Newswire·

Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...